STROBE-MR声明:孟德尔随机化研究报道规范
STROBE-MR是STROBE指南的独立扩展,用于规范孟德尔随机化(MR)研究的报道。该声明由17位专家依据EQUATOR框架制定,包含6个部分、20个主条目和30个亚条目,覆盖1样本和2样本MR研究,要求作者论证MR适用性、报告遗传变异选择与质量、评估MR特异性假设有效性及数据共享。
要点
- STROBE-MR含6部分20主条目30亚条目,适用于1样本和2样本MR研究。
- 作者需论证MR是回答研究问题的有用方法,并预先设定因果假设。
- 需报告遗传变异的测量、质量与选择,并评估MR特异性假设的有效性。
核心结论
- STROBE-MR为孟德尔随机化研究提供报道指南,改善报道可促进编辑、同行审稿人、研究人员、临床医生等对研究的评估和结果解读。
研究设计与样本
- 遵循EQUATOR框架指导,以STROBE声明为起点起草针对MR研究的清单,项目于2018年启动。
- 17位专家(包括MR方法学家、MR研究设计使用者、既往报道指南制定者和期刊编辑)参与2019年5月研讨会,确定声明范围并起草清单。
- 清单草案于2019年7月作为预印本发布,经预印本平台、社交媒体和第四届孟德尔随机化会议讨论,根据意见修订,2020年进一步细化,2021年7月定稿。
主要发现
- STROBE-MR清单分为6个部分(标题与摘要、引言、方法、结果、讨论、其他信息),包括20个主条目和30个亚条目。
- 清单覆盖评估1个或多个暴露与结局的1样本和2样本MR研究,以及在同一文章中报道的全基因组关联研究后的MR研究。
- 清单要求作者论证MR是解决研究问题的有用方法,并陈述预先设定的因果假设。
- 必须描述遗传变异的测量、质量和选择,并充分报告评估MR特异性假设有效性的尝试。
- 数据共享条目包括报告何时可获取复制分析所需的数据和统计代码。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Mendelian randomization (MR) studies use genetic variation associated with modifiable exposures to assess their possible causal relationship with outcomes and aim to reduce potential bias from confounding and reverse causation. OBJECTIVE: To develop the STROBE-MR Statement as a stand-alone extension to the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guideline for the reporting of MR studies. DESIGN, SETTING, AND PARTICIPANTS: The development of the STROBE-MR Statement followed the Enhancing the Quality and Transparency of Health Research (EQUATOR) framework guidance and used the STROBE Statement as a starting point to draft a checklist tailored to MR studies. The project was initiated in 2018 by reviewing the literature on the reporting of instrumental variable and MR studies. A group of 17 experts, including MR methodologists, MR study design users, developers of previous reporting guidelines, and journal editors, participated in a workshop in May 2019 to define the scope of the Statement and draft the checklist. The draft checklist was published as a preprint in July 2019 and discussed on the preprint platform, in social media, and at the 4th Mendelian Randomization Conference. The checklist was then revised based on comments, further refined through 2020, and finalized in July 2021. FINDINGS: The STROBE-MR checklist is organized into 6 sections (Title and Abstract, Introduction, Methods, Results, Discussion, and Other Information) and includes 20 main items and 30 subitems. It covers both 1-sample and 2-sample MR studies that assess 1 or multiple exposures and outcomes, and addresses MR studies that follow a genome-wide association study and are reported in the same article. The checklist asks authors to justify why MR is a helpful method to address the study question and state prespecified causal hypotheses. The measurement, quality, and selection of genetic variants must be described and attempts to assess validity of MR-specific assumptions should be well reported. An item on data sharing includes reporting when the data and statistical code required to replicate the analyses can be accessed. CONCLUSIONS AND RELEVANCE: STROBE-MR provides guidelines for reporting MR studies. Improved reporting of these studies could facilitate their evaluation by editors, peer reviewers, researchers, clinicians, and other readers, and enhance the interpretation of their results.
引用
- Skrivankova VW, Richmond RC, Woolf BAR, et al. Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement. JAMA. 2021. PMID: 34698778. doi:10.1001/jama.2021.18236
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。